FDA’s New Device Review Policy Hits Some Speed Bumps

Law360, New York (March 22, 2013, 7:39 PM EDT) -- Medical device attorneys are raising concerns that the Food and Drug Administration is unevenly implementing a new policy intended to accelerate product reviews, saying the new approval process has so far been unpredictable and could actually lengthen the time it takes a product to hit the market.

At the end of 2012, the FDA officially adopted a "refuse-to-accept" policy for a type of application for premarketing review — the 510(k) — that applies to less risky products. Under the policy, the FDA has 15 days to make...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.